Candesartan vs Empagliflozin

Candesartan vs Empagliflozin: Overview

This comparison examines the pharmacological differences between Candesartan and Empagliflozin.

Mechanism of Action

Candesartan: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Pharmacokinetics

Half-life: Candesartan — 9 hours; Empagliflozin — 12.4 hours.

Chemical Properties

Molecular Formula: Candesartan — C33H34N6O6; Empagliflozin — C23H27ClO7.

Molecular Weight: Candesartan — 610.6640 g/mol; Empagliflozin — 450.9100 g/mol.

Type: Candesartan — Small molecule; Empagliflozin — Small molecule.